1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Retention Disorders, Cognitive: new trials by email Literature Review of Retention Disorders, Cognitive trials Research Report on Retention Disorders, Cognitive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints EGb 761® (Tanakan®), Placebo - Memory Disorders, Age-Related, Retention Disorders, Cognitive | Phase 4 | Completed | Ipsen | 2878 | 2002-02-01 | 2019-01-15 |
Memory Disorders (1)
Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Ipsen (1)
France (1)